Scrip
No increased cancer risk seen in long-term Lantus trial
10 July 2009
Malini Guha
The longest, five-year, randomised controlled study comparing Sanofi-Aventis's long-acting, once-daily insulin analogue Lantus (insulin glargine) with human NPH (neutral protamine Hagedorn) insulin has not shown a higher incidence of cancer with Lantus, and similar effects on diabetic retinopathy, which...
Please Login to read the full article.
10 July 2009
Malini Guha
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
